Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine
Abstract Background & aims Although metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with high multimorbidity and mortality, existing classification systems and risk prediction models largely ignore the heterogeneity of MASLD. Improved subtype definition could impro...
Saved in:
| Main Authors: | Chang Hong, Sheng-xing Liang, Ze-yang Li, Rui-ning Li, Hong-bo Zhu, Mingfei He, Hao Cui, Jing-zhe He, Yan Li, Jia-ren Wang, Xue-jing Zou, Wen-yuan Li, Lin Zeng, Li Liu, Lu-shan Xiao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06670-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis
by: Gina Ryu, et al.
Published: (2025-01-01) -
Association between trans-palmitoleic acid and metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma: NHANES 1999–2018
by: Qirui Li, et al.
Published: (2025-06-01) -
Genetic variants influencing liver fat in normal-weight individuals of European ancestry
by: Ignazio S. Piras, et al.
Published: (2025-08-01) -
Association between cardiovascular health and metabolic dysfunction-associated steatotic liver disease: a nationwide cross-sectional study
by: Lian-Zhen Huang, et al.
Published: (2025-01-01) -
Microbiota and metabolic dysfunction associated with steatotic liver disease
by: Q. Zhu, et al.
Published: (2024-09-01)